membrane
发表于 2025-4-1 02:41:18
Chronic Myeloproliferative Disorders:From Molecular Pathogenesis to Targeted Therapy,f safe and effective therapies will soon follow. This principle has previously been demonstrated in malignant hematology by the effectiveness of . kinase inhibitors in chronic myelogenous leukemia (CML). A new opportunity to deliver on this premise is underway in the closely related non-CML myeloproliferative neoplasms (MPNs).